ShrujalSubhashBaxiMDMPH

PubMed

• Inter- and Intraobserver Variability on Endoscopic Scoring Systems in Crohn's Disease and Ulcerative Colitis: A Systematic Review and Meta-Analysis.
  Jana G Hashash, Faye Yu Ci Ng, Yeli Wang, Daniel R Colucci, Sadaf Muneer, Mitchell Reddan, Pratik Shingru, Francis A Farraye, Shrujal Baxi, Gil Y Melmed> ;Inflammatory Bowel Diseases. 2024 Mar 28
• Outcomes in biomarker-selected subgroups from the KESTREL study of durvalumab and tremelimumab in recurrent or metastatic head and neck squamous cell carcinoma.
  Tanguy Y Seiwert, Sophie Wildsmith, Jérôme Fayette, Kevin Harrington, Maura Gillison, Myung-Ju Ahn, Shunji Takahashi, Jared Weiss, Jean-Pascal Machiels, Shrujal Baxi, ...> ;Cancer Immunology, Immunotherapy. 2024 Mar 2
• 1 citations
  Evaluation of US oncology electronic health record real-world data to reduce uncertainty in health technology appraisals: a retrospective cohort study.
  Philani Mpofu, Seamus Kent, Páll Jónsson, Harlan Pittell, Brad Groves, Ivy Altomare, Amanda Copeland, Shrujal Baxi, Danielle Bargo, Arun Sujenthiran, Blythe Adamson> ;BMJ Open. 2023 Oct 17
• Identifying the mechanism of missingness for unspecified diabetic retinopathy disease severity in the electronic health record: an IRIS® Registry analysis.
  Meghan Hatfield, Thai Hien Nguyen, Richard Chapman, Alayna C Myrick, Theodore Leng, Michael Mbagwu, Shrujal Baxi, Aracelis Z Torres, Durga S Borkar> ;Journal of the American Medical Informatics Association. 2023 May 19
• 29 citations
  Durvalumab with or without tremelimumab versus the EXTREME regimen as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck: KE...
  A Psyrri, J Fayette, K Harrington, M Gillison, M-J Ahn, S Takahashi, J Weiss, J-P Machiels, S Baxi, A Vasilyev, A Karpenko, M Dvorkin, C-Y Hsieh, S C Thungappa, P P Se...> ;Annals of Oncology. 2023 Mar 1
• 5 citations
  Augmenting control arms with real-world data for cancer trials: Hybrid control arm methods and considerations.
  W Katherine Tan, Brian D Segal, Melissa D Curtis, Shrujal S Baxi, William B Capra, Elizabeth Garrett-Mayer, Brian P Hobbs, David S Hong, Rebecca A Hubbard, Jiawen Zhu,...> ;Contemporary Clinical Trials Communications. 2022 Dec 1
• 2 citations
  Associations Between Race/Ethnicity, Language, and Enrollment on Cancer Research Studies.
  Ogochukwu M Ezeoke, Gary Brooks, Michael A Postow, Shrujal Baxi, Soo Young Kim, Bharat Narang, Lisa C Diamond> ;The Oncologist. 2023 Feb 8
• 24 citations
  Enhancing Radioiodine Incorporation in-Mutant, Radioiodine-Refractory Thyroid Cancers with Vemurafenib and the Anti-ErbB3 Monoclonal Antibody CDX-3379: Results of a Pi...
  Vatche Tchekmedyian, Lara Dunn, Eric Sherman, Shrujal S Baxi, Ravinder K Grewal, Steven M Larson, Keith S Pentlow, Sofia Haque, R Michael Tuttle, Mona M Sabra, Stephan...> ;Thyroid. 2022 Mar 1
• 10 citations
  Real-world Overall Survival Using Oncology Electronic Health Record Data: Friends of Cancer Research Pilot.
  Laura Lasiter, Olga Tymejczyk, Elizabeth Garrett-Mayer, Shrujal S. Baxi, Andrew J. Belli, Marley Boyd, Jennifer B. Christian, Aaron B Cohen, Janet L. Espirito, Eric Ha...> ;Clinical Pharmacology and Therapeutics. 2021 Nov 2
• 2 citations
  Approaches for Enhanced Extrapolation of Long-Term Survival Outcomes Using Electronic Health Records of Patients With Cancer
  Xiaoliang Wang, Blythe J.S. Adamson, Andrew Briggs, Katherine Tan, Danielle Bargo, Shuhag Ghosh, Shrujal S. Baxi, Scott D. Ramsey> ;Value in Health. 2021 Oct 6
• 5 citations
  Real-world time on treatment with immuno-oncology therapy in recurrent/metastatic head and neck squamous cell carcinoma.
  Karthik Ramakrishnan, Zhiwen Liu, Shrujal S. Baxi, Sheenu Chandwani, Sam Joo, Diana Chirovsky> ;Future Oncology. 2021 May 28
• 197 citations
  Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma.
  Sean McBride, Eric J. Sherman, C. Jillian Tsai, Shrujal S. Baxi, Jahan Aghalar, Juliana Eng, Wanqing Iris Zhi, Daniel C. McFarland, Loren S. Michel, Robert J. Young, R...> ;Journal of Clinical Oncology. 2021 Jan 1
• 6 citations
  Using electronic health record data to identify comparator populations for comparative effectiveness research.
  Scott D. Ramsey, Blythe J.S. Adamson, Xiaoliang Wang, Danielle Bargo, Shrujal S. Baxi, Shuhag Ghosh, Neal J. Meropol> ;Journal of Medical Economics. 2020 Nov 10
• 16 citations
  The experience of financial toxicity among advanced melanoma patients treated with immunotherapy
  Bridgette Thom, Maha Mamoor, Jessica A. Lavery, Shrujal S. Baxi, Niloufer Khan, Lauren J. Rogak, Robert Sidlow, Deborah Korenstein> ;Journal of Psychosocial Oncology. 2021 Mar 4
• 7 citations
  Organ Dysfunction in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors
  Susan Spillane, Shrujal S. Baxi, Aracelis Z. Torres, David Lenis, Andrew N. Freedman, Angela B. Mariotto, Elad Sharon> ;The Oncologist. 2020 Nov 1
• 2 citations
  Letting the GENIE Out of Its Bottle: Examining the Potential of Real-World Clinicogenomic Data.
  Emily Castellanos, Shrujal S. Baxi> ;Cancer Discovery. 2020 Apr 1
• 37 citations
  A Phase 1b Study of Cetuximab and BYL719 (Alpelisib) Concurrent with Intensity Modulated Radiation Therapy in Stage III-IVB Head and Neck Squamous Cell Carcinoma.
  Lara Dunn, Nadeem Riaz, Matthew G. Fury, Sean McBride, Loren S. Michel, Nancy Y. Lee, Eric J. Sherman, Shrujal S. Baxi, Sofia Haque, Nora Katabi, Richard J. Wong, Han ...> ;International Journal of Radiation Oncology, Biology, Physics. 2020 Mar 1
• 32 citations
  Quality of life in long-term survivors of advanced melanoma treated with checkpoint inhibitors.
  Maha Mamoor, Michael A. Postow, Jessica A. Lavery, Shrujal S. Baxi, Niloufer Khan, Jun J. Mao, Lauren J. Rogak, Robert Sidlow, Bridgette Thom, Jedd A Wolchok, Deborah ...> ;Journal for Immunotherapy of Cancer. 2020 Mar 1
• 10 citations
  First-line immune checkpoint inhibitor use in cisplatin-eligible patients with advanced urothelial carcinoma: a secular trend analysis.
  Ravi B. Parikh, Emily Feld, Matthew D. Galsky, Blythe Js Adamson, Aaron B Cohen, Shrujal S. Baxi, Shimon Ben Boursi, John P. Christodouleas, David J. Vaughn, Neal J. M...> ;Future Oncology. 2020 Jan 1
• 18 citations
  Association Between FDA Label Restriction and Immunotherapy and Chemotherapy Use in Bladder Cancer
  Ravi B. Parikh, Blythe J.S. Adamson, Sean Khozin, Matthew D. Galsky, Shrujal S. Baxi, Aaron Cohen, Ronac Mamtani> ;JAMA. 2019 Sep 24
• 3 citations
  Phase 2 study of vascular endothelial growth factor trap for the treatment of metastatic thyroid cancer.
  Eric J. Sherman, Lara Dunn, Heiko Schöder, Alan L. Ho, Shrujal S. Baxi, Ronald Ghossein, Sofia Haque, Cami Sima, Robert Michael Tuttle, David G. Pfister> ;Cancer. 2019 Sep 1
• 119 citations
  Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers.
  Lara Dunn, Eric J. Sherman, Shrujal S. Baxi, Vatche Tchekmedyian, Ravinder K. Grewal, Steven M. Larson, Keith S. Pentlow, Sofia Haque, R. Michael Tuttle, Mona M. Sabra...> ;The Journal of Clinical Endocrinology and Metabolism. 2019 May 1
• Automating Treatment Summary Development Using Electronic Billing Information: A Pilot Study of Survivors of Head and Neck Cancer
  Shrujal S. Baxi, Ranjit Sukhu, Elizabeth Fortier, Kevin C. Oeffinger, Stacie Corcoran, Andrew L. Salner, Andrew J. Vickers, Mary S. McCabe, Talya Salz> ;Journal of Oncology Practice. 2019 Jan 1
• 6 citations
  Long-term quality of life in older patients with HPV-related oropharyngeal cancer.
  Shrujal S. Baxi, Grace Cullen, Han Xiao, Coral L. Atoria, Eric J. Sherman, Alan L. Ho, Nancy Y. Lee, Elena B. Elkin, David G. Pfister> ;Head & Neck. 2018 Nov 1
• 1 citations
  A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell ca...
  L A Dunn, M G Fury, H Xiao, S S Baxi, E J Sherman, S Korte, C Pfister, S Haque, N Katabi, A L Ho, D G Pfister> ;Annals of Oncology. 2018 Jul 1
• Join now to see all